Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

Ryan C. Kelm, Erika L. Hagstrom, Regine J. Mathieu, Kelsey A. Orrell, Linda Serrano, Kelly A. Mueller, Anne E. Laumann, Dennis P. West, Beatrice Nardone*

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)820-821
Number of pages2
JournalJournal of the American Academy of Dermatology
Volume80
Issue number3
DOIs
StatePublished - Mar 2019

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Melanoma
Research
Natalizumab

ASJC Scopus subject areas

  • Dermatology

Cite this

Kelm, Ryan C. ; Hagstrom, Erika L. ; Mathieu, Regine J. ; Orrell, Kelsey A. ; Serrano, Linda ; Mueller, Kelly A. ; Laumann, Anne E. ; West, Dennis P. ; Nardone, Beatrice. / Melanoma subsequent to natalizumab exposure : A report from the RADAR (Research on Adverse Drug events And Reports) program. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 80, No. 3. pp. 820-821.
@article{b1c54bf1a28649debe83381ae14fabf6,
title = "Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program",
author = "Kelm, {Ryan C.} and Hagstrom, {Erika L.} and Mathieu, {Regine J.} and Orrell, {Kelsey A.} and Linda Serrano and Mueller, {Kelly A.} and Laumann, {Anne E.} and West, {Dennis P.} and Beatrice Nardone",
year = "2019",
month = "3",
doi = "10.1016/j.jaad.2018.10.052",
language = "English (US)",
volume = "80",
pages = "820--821",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

Melanoma subsequent to natalizumab exposure : A report from the RADAR (Research on Adverse Drug events And Reports) program. / Kelm, Ryan C.; Hagstrom, Erika L.; Mathieu, Regine J.; Orrell, Kelsey A.; Serrano, Linda; Mueller, Kelly A.; Laumann, Anne E.; West, Dennis P.; Nardone, Beatrice.

In: Journal of the American Academy of Dermatology, Vol. 80, No. 3, 03.2019, p. 820-821.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Melanoma subsequent to natalizumab exposure

T2 - A report from the RADAR (Research on Adverse Drug events And Reports) program

AU - Kelm, Ryan C.

AU - Hagstrom, Erika L.

AU - Mathieu, Regine J.

AU - Orrell, Kelsey A.

AU - Serrano, Linda

AU - Mueller, Kelly A.

AU - Laumann, Anne E.

AU - West, Dennis P.

AU - Nardone, Beatrice

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85057275766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057275766&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.10.052

DO - 10.1016/j.jaad.2018.10.052

M3 - Article

C2 - 30395915

AN - SCOPUS:85057275766

VL - 80

SP - 820

EP - 821

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -